Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.
Location: Canada, Quebec, Montreal
Employees: 11-50
Total raised: $17M
Founded date: 2017
Investors 5
| Date | Name | Website |
| 31.01.2022 | Y Combinat... | ycombinato... |
| 22.12.2021 | Lux Capita... | luxcapital... |
| - | Real Ventu... | realventur... |
| 04.05.2022 | First Star... | firststar.... |
| 16.12.2021 | SR One | srone.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.12.2021 | Series A | $17M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 09.12.2021 | Nomic Bio Raises $17M in Series A Funding | Nomic Bio (formerly nplex biosciences), a Montreal, Canada-based protein profiling company, raised $... | finsmes.co... |
| 08.12.2021 | Rebranded Nomic Bio raises $17 million to fuel development o... | Nomic Bio has secured a new name and $17 million USD in Series A financing to support the growth of ... | betakit.co... |